Why 9 Out of 10 New Drugs Fail, and the Spokane Startup Fixing It
Why do 93% of drug candidates fail once they reach clinical trials? Chandima Bandaranayaka, CEO of Precision Quantomics, explains the hidden data gap behind failed drugs, the $2 billion cost of bringing one to market, and how proteomics and AI could help close it.
On Episode 43 of the Cowles Ventures Podcast, Blake Gibson sits down with Chandima to break down how his Spokane biotech company, spun out of WSU research, is building what he calls a Google Maps for drug development: a protein-level data layer that helps pharma companies predict how a drug will behave in humans before it ever…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.